Clinical trial
Determination of the 90% Effective Dose of the Initial Bolus of Norepinephrine in Elective Cesarean Section: An Up-Down Study
NCT06574555 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the 90% Effective Dose of the Initial Bolus of Norepinephrine in Elective Cesarean Section: An Up-Down Study
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2025
- Completion date
- August 2, 2025
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia, hypertension, hypotension, nausea, pain